Piqray 250 MG daily dose pack 56S
Ended Awarded
- Contract number
- SPE2DB25FH0A9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,398
Award facts
- Contract value 100% obligated
- $13,397.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for PIQRAY 250 mg daily dose packs (56-count units) with a ceiling value of $13,397.89. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company serves as a prime vendor through DLA's Medical Supply Chain, fulfilling orders for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. PIQRAY (alpelisib), an oncology therapeutic, represents part of the company's extensive portfolio of specialty medications delivered through competitive federal contracts. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning vendors like AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DB25FH0A9?
SPE2DB25FH0A9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FH0A9 worth?
The government has obligated $13,398 on SPE2DB25FH0A9.
Is contract SPE2DB25FH0A9 an order under another contract?
Yes. SPE2DB25FH0A9 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH0A9 competed?
The extent of competition for SPE2DB25FH0A9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award